Back to search

Article

Gut Microbiota a Novel Source of Biomarkers for Immunotherapy in Non-small Cell Lung Cancer (NSCLC)

2024-03-15

Abstract excerpt

Despite the recent availability of immune checkpoint inhibitors, not all patients affected by Non-Small Cell Lung Cancer (NSCLC) benefit from immunotherapy. The reason for this variability relies to a variety of factors which may allow the identification of novel biomarkers. Presently, a variety of biomarkers are under investigation, including the PD1/PDL1 axis, the tumor mutational burden, and the Microbiota. Thi...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8d4f7ed5-cf7e-5b4a-ba94-70a609a8ce07
DOI
10.20944/preprints202403.0902.v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Gut Microbiota a Novel Source of Biomarkers for Immunotherapy in Non-small Cell Lung Cancer (NSCLC)DOI 10.20944/preprints202403.0902.v1
Understanding Microbiome Effect on Immune Checkpoint Inhibition in Lung Cancer: Placing the Puzzle Pieces TogetherSemantic proximity
Gut Microbiota in Lung Cancer: Where Do We Stand?Semantic proximity
Human Microbiome as Clinical Biomarkers for Respiratory Tract CancersSemantic proximity
A review on the role of gut microbiota in immune checkpoint blockade therapy for cancerSemantic proximity
Response to PD-1-Based Immunotherapy for Non-Small Cell Lung Cancer Altered by Gut MicrobiotaSemantic proximity
Roles of microbiota in response to cancer immunotherapySemantic proximity
Gut Microbiota: A Potential Target for Cancer InterventionsSemantic proximity
The Complex Role of the Microbiome in Non-Small Cell Lung Cancer Development and ProgressionSemantic proximity
Gut microbiota as a biomarker and modulator of anti-tumor immunotherapy outcomesSemantic proximity
The microbiome in the pathogenesis of lung cancerSemantic proximity
The intimate relationship between gut microbiota and cancer immunotherapySemantic proximity
Role of gut microbiome in cancer immunotherapy: from predictive biomarker to therapeutic targetSemantic proximity
Select a neighboring publication to make it the new centre.